Sort
39,280 grants matching “leukemia”
The function and underlying mechanism of TET1 in myelodysplastic syndromes
$548,659Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2023 · DK
Project 3
$548,644Branden S Moriarity · University Of Minnesota · P01 · FY2025 · CA
Project 3
$548,644Branden S Moriarity · University Of Minnesota · P01 · FY2021 · CA
Enhancer Dysregulation in AML
$548,610Yali Dou · University Of Southern California · R01 · FY2022 · CA
Enhancer Dysregulation in AML
$548,610Yali Dou · University Of Southern California · R01 · FY2023 · CA
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma
$548,529Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma
$548,529Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma
$548,529Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA
Trpm2: A novel target in Onco-cardiology
$548,502Joseph Y Cheung · Temple Univ Of The Commonwealth · R01 · FY2018 · HL
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
$548,492Robert G Roeder · Rockefeller University · R01 · FY2014 · CA
Biochemistry of Leukemia Virus Core Binding Factor
$548,328Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2019 · HL
Biochemistry of Leukemia Virus Core Binding Factor
$548,328Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2020 · HL
Preventing Fatal Infections in Children with Down Syndrome During Treatment for Acute Lymphoblastic Leukemia
$548,211Sandra W Ryeom · Columbia University Health Sciences · R01 · FY2024 · CA
Hematopoietic stem cell gene therapy for sickle cell disease
$548,197Derek A Persons · St. Jude Children'S Research Hospital · U54 · FY2008 · HL
Characterization of the LGL Leukemia Virus (PQ 12)
$548,147Thomas P Loughran · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2012 · CA
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis
$548,019David W. Clapp · Indiana University Indianapolis · R01 · FY2020 · HL
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY
$547,924Georgetown University · U10 · FY2002 · CA
Emergency Myelopoiesis in the Pathogenesis of Myeloid Malignancies
$547,907Emmanuelle Passegue · Columbia University Health Sciences · R01 · FY2021 · CA
Emergency Myelopoiesis in the Pathogenesis of Myeloid Malignancies
$547,907Emmanuelle Passegue · Columbia University Health Sciences · R01 · FY2025 · CA
Childhood Leukemia: Oxidative Stress, Cognitive Changes & Academic Outcomes
$547,867Ida Marie Moore · University Of Arizona · R01 · FY2012 · NR
Hematopoietic Stem and Progenitor Cell Expansion
$547,838Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
$547,763Kara Lynn Davis · Stanford University · R01 · FY2024 · CA
Targeting Tumors with NF1 Loss
$547,736Yolanda Sanchez · Dartmouth College · R01 · FY2016 · NS
Molecular screening: MALDI-TOF scanning of peptides (RMI)
$547,706Stephen J. Kron · University Of Chicago · R01 · FY2008 · HG
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)
$547,579Elaine R Mardis · Washington University · U01 · FY2013 · GM